Nifty
Sensex
:
:
11250.55
38034.14
-254.40 (-2.21%)
-811.68 (-2.09%)

Pharmaceuticals & Drugs - API

Rating :
77/99  (View)

BSE: 532488 | NSE: DIVISLAB

3158.80
-185.60 (-5.55%)
21-Sep-2020 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  3350.95
  •  3374.25
  •  3120.05
  •  3344.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1585479
  •  50082.11
  •  3389.00
  •  1587.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 83,874.80
  • 52.55
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 83,785.80
  • 0.51%
  • 10.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.97%
  • 1.37%
  • 8.59%
  • FII
  • DII
  • Others
  • 18.17%
  • 15.57%
  • 4.33%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.15
  • 7.39
  • 11.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.79
  • 5.15
  • 7.62

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.36
  • 4.10
  • 16.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.36
  • 31.74
  • 34.50

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.67
  • 8.67
  • 8.67

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.91
  • 21.43
  • 24.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
1,730
1,163
49%
1,390
0
0
1,396
1,360
3%
1,446
1,324
9%
Expenses
1,030
776
33%
945
0
0
902
827
9%
955
802
19%
EBITDA
700
387
81%
444
0
0
494
533
-7%
491
521
-6%
EBIDTM
40%
33%
14%
0%
35%
39%
34%
39%
Other Income
17
30
-43%
77
0
0
42
34
21%
47
80
-42%
Interest
0
0
-28%
0
0
0
2
3
-38%
4
0
1479%
Depreciation
56
44
28%
50
0
0
47
42
10%
46
42
8%
PBT
661
373
77%
471
0
0
487
522
-7%
488
559
-13%
Tax
169
101
67%
83
0
0
128
133
-4%
131
156
-16%
PAT
492
272
81%
388
0
0
359
389
-8%
357
404
-12%
PATM
28%
23%
7%
0%
26%
29%
25%
30%
EPS
18.53
10.26
81%
14.62
0.00
0
13.53
14.67
-8%
13.44
15.21
-12%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
5,394
4,946
3,891
4,064
3,776
3,115
2,532
2,145
1,864
1,317
Net Sales Growth
-
9%
27%
-4%
8%
21%
23%
18%
15%
42%
 
Cost Of Goods Sold
-
2,109
1,825
1,534
1,534
1,505
1,213
914
799
762
513
Gross Profit
-
3,286
3,121
2,357
2,530
2,271
1,902
1,618
1,346
1,102
804
GP Margin
-
61%
63%
61%
62%
60%
61%
64%
63%
59%
61%
Total Expenditure
-
3,571
3,073
2,629
2,617
2,358
1,949
1,517
1,329
1,173
816
Power & Fuel Cost
-
281
249
229
199
180
171
147
131
86
63
% Of Sales
-
5%
5%
6%
5%
5%
5%
6%
6%
5%
5%
Employee Cost
-
621
542
456
500
361
290
232
198
151
117
% Of Sales
-
12%
11%
12%
12%
10%
9%
9%
9%
8%
9%
Manufacturing Exp.
-
259
213
183
169
169
147
121
105
87
65
% Of Sales
-
5%
4%
5%
4%
4%
5%
5%
5%
5%
5%
General & Admin Exp.
-
149
105
139
88
74
64
52
44
32
28
% Of Sales
-
3%
2%
4%
2%
2%
2%
2%
2%
2%
2%
Selling & Distn. Exp.
-
85
73
64
67
56
52
44
51
54
30
% Of Sales
-
2%
1%
2%
2%
1%
2%
2%
2%
3%
2%
Miscellaneous Exp.
-
68
66
24
60
12
11
6
1
1
30
% Of Sales
-
1%
1%
1%
1%
0%
0%
0%
0%
0%
0%
EBITDA
-
1,823
1,873
1,263
1,447
1,418
1,166
1,015
816
691
501
EBITDA Margin
-
34%
38%
32%
36%
38%
37%
40%
38%
37%
38%
Other Income
-
190
156
113
75
97
45
71
45
56
27
Interest
-
7
5
2
3
5
3
3
3
5
2
Depreciation
-
186
169
142
123
118
136
92
77
62
53
PBT
-
1,819
1,855
1,231
1,395
1,393
1,072
991
781
681
472
Tax
-
443
502
354
335
267
221
218
179
147
43
Tax Rate
-
24%
27%
29%
24%
19%
21%
22%
23%
22%
9%
PAT
-
1,377
1,353
877
1,060
1,126
852
773
602
533
429
PAT before Minority Interest
-
1,377
1,353
877
1,060
1,126
852
773
602
533
429
Minority Interest
-
0
0
0
0
0
0
0
0
0
0
PAT Margin
-
26%
27%
23%
26%
30%
27%
31%
28%
29%
33%
PAT Growth
-
2%
54%
-17%
-6%
32%
10%
28%
13%
24%
 
EPS
-
51.85
50.95
33.03
39.94
42.40
32.07
29.13
22.67
20.09
16.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
7,310
6,957
5,925
5,357
4,293
3,495
2,963
2,501
2,132
1,797
Share Capital
53
53
53
53
53
27
27
27
27
27
Total Reserves
7,257
6,904
5,872
5,304
4,240
3,469
2,937
2,474
2,105
1,770
Non-Current Liabilities
295
991
1,769
1,412
85
842
650
470
71
67
Secured Loans
0
0
0
0
0
0
0
0
0
2
Unsecured Loans
0
0
0
0
0
1
2
2
3
3
Long Term Provisions
21
773
1,577
1,289
12
714
533
388
2
3
Current Liabilities
1,821
847
653
659
520
776
627
554
554
410
Trade Payables
591
492
411
446
233
227
152
160
160
123
Other Current Liabilities
290
244
175
177
241
203
148
130
136
105
Short Term Borrowings
34
106
63
36
41
25
16
31
50
14
Short Term Provisions
906
5
4
1
5
320
312
233
208
168
Total Liabilities
9,425
8,795
8,347
7,429
4,898
5,112
4,241
3,525
2,757
2,275
Net Block
2,782
2,088
1,996
1,559
1,439
1,309
1,222
909
738
590
Gross Block
3,514
2,634
2,373
1,794
2,196
1,953
1,740
1,338
1,092
886
Accumulated Depreciation
732
546
377
235
757
644
518
430
354
296
Non Current Assets
3,851
4,145
3,812
3,418
1,871
2,340
1,984
1,661
1,006
734
Capital Work in Progress
920
492
120
444
264
218
144
303
182
104
Non Current Investment
0
547
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
144
1,013
1,688
1,406
162
813
618
448
84
38
Other Non Current Assets
5
5
8
9
6
0
0
0
2
2
Current Assets
5,574
4,650
4,535
4,011
3,027
2,772
2,256
1,864
1,751
1,541
Current Investments
971
1,398
1,889
1,631
803
733
502
408
477
526
Inventories
1,864
1,772
1,351
1,320
1,208
1,163
932
836
679
572
Sundry Debtors
1,413
1,163
1,014
901
881
742
724
512
495
365
Cash & Bank
123
115
112
79
73
65
41
41
31
18
Other Current Assets
1,202
142
125
21
62
70
58
68
69
60
Short Term Loans & Adv.
1,000
59
43
60
43
55
48
58
63
57
Net Current Assets
3,753
3,803
3,882
3,351
2,508
1,997
1,629
1,310
1,197
1,131
Total Assets
9,425
8,795
8,347
7,429
4,898
5,112
4,241
3,525
2,757
2,275

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,216
954
776
1,150
1,038
826
557
480
338
327
PBT
1,819
1,855
1,231
1,395
1,393
1,072
991
781
681
472
Adjustment
60
84
32
94
61
91
78
59
27
27
Changes in Working Capital
-218
-500
-219
-37
-155
-126
-298
-186
-242
-139
Cash after chg. in Working capital
1,661
1,439
1,044
1,452
1,299
1,038
770
654
465
360
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-445
-484
-269
-302
-261
-211
-213
-174
-127
-33
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-83
-685
-478
-1,140
-406
-521
-305
-255
-204
-221
Net Fixed Assets
-1,303
-633
-256
222
-289
-286
-243
-368
-284
-133
Net Investments
974
-56
-258
-826
-77
-231
-94
69
49
-87
Others
245
3
35
-536
-40
-3
32
44
31
-2
Cash from Financing Activity
-1,091
-246
-314
2
-631
-303
-248
-231
-131
-104
Net Cash Inflow / Outflow
41
23
-17
13
0
3
3
-5
3
1
Opening Cash & Equivalents
2
-21
-4
-17
18
15
12
17
14
13
Closing Cash & Equivalent
43
2
-21
-4
18
18
15
12
17
14

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
275
262
223
202
162
132
112
94
80
68
ROA
15%
16%
11%
17%
22%
18%
20%
19%
21%
21%
ROE
19%
21%
16%
22%
29%
26%
28%
26%
27%
26%
ROCE
25%
28%
22%
29%
36%
33%
36%
33%
34%
28%
Fixed Asset Turnover
1.75
1.98
1.88
2.06
1.83
1.70
1.66
1.78
1.90
1.55
Receivable days
87
80
89
79
78
85
88
85
83
81
Inventory Days
123
115
125
112
114
122
127
128
121
147
Payable days
55
52
60
47
35
34
36
42
43
63
Cash Conversion Cycle
155
143
154
144
156
173
179
171
162
164
Total Debt/Equity
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
Interest Cover
256
397
521
416
295
374
336
303
149
210

News Update


  • Divi’s Laboratories reports 80% rise in Q1 consolidated net profit
    10th Aug 2020, 11:15 AM

    Total consolidated income of the company increased by 46.48% at Rs 1747.80 crore for Q1FY21

    Read More
  • Divis Lab - Quarterly Results
    8th Aug 2020, 12:37 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.